Detalhe da pesquisa
1.
Hepatic steatosis with significant fibrosis is associated with an increased 10-year estimated risk of cardiovascular disease in adults with type 1 diabetes mellitus.
Cardiovasc Diabetol
; 22(1): 204, 2023 08 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37563618
2.
MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus.
Diabetes Metab
; 50(1): 101497, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-37992857
3.
Sex Differences in Cardiovascular Disease and Cardiovascular Risk Estimation in Patients With Type 1 Diabetes.
J Clin Endocrinol Metab
; 108(9): e789-e798, 2023 08 18.
Artigo
Inglês
| MEDLINE | ID: mdl-36881927
4.
Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus.
Diabetes Metab
; 49(6): 101477, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37708990
5.
Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired ß-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.
J Clin Endocrinol Metab
; 98(5): 2100-5, 2013 May.
Artigo
Inglês
| MEDLINE | ID: mdl-23539736
6.
Pathogenetic mechanisms and cardiovascular risk: differences between HbA(1c) and oral glucose tolerance test for the diagnosis of glucose tolerance.
Diabetes Care
; 35(12): 2607-12, 2012 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-22912427